Parallax Health Sciences, Inc. Subsidiary QOLPOM, Inc. has been Renamed as Parallax Health Management, Inc.

Computer Weekly News

By a News Reporter-Staff News Editor at Computer Weekly News -- Parallax Health Sciences, Inc. ("Parallax") (OTCQB:PRLX), completed the acquisition of QOLPOM, Inc. in 2016, and has now changed the subsidiary's name to Parallax Health Management, Inc.

"The acquisition of Parallax Health Management, Inc. was an important step for Parallax to address the increasing influence of the Internet of Things on the health care industry and the rapidly growing remote patient monitoring and telehealth sectors," said Parallax Health Management, Inc. President, Nathan Bradley. "Parallax Health Management, Inc. has an established nationwide base of leading hospitals, nursing homes, insurance and rehabilitation customers, giving Parallax a valuable platform by which to expand its presence in new market segments," added Mr. Bradley.

Parallax Health Management, Inc. brings the key components of systems integration to the telehealth market together by utilizing best in class hardware and software components combined with its own proprietary technologies. Parallax Health Management, Inc. systems are hosted on the Microsoft Azure Cloud offering the best in security and scalability.

"Our support call centers are state of the art and have been accredited by CARF, the Commission for Accreditation of Rehabilitation Facilities and by the American Association of Suicidology (AAS)," said Michael Redmond, Chief Executive Officer of Parallax Health Sciences, Inc. "Our business model is selling service, and we use the finest tools, hardware and proprietary software to provide world class services that our clients deserve and expect."

"Parallax Health Management, Inc. is a perfect fit to Parallax, with numerous revenue enhancing synergies providing the blueprint for next-generation healthcare solutions. The acquisition continues to proceed better than expected and we look forward to accelerated growth in 2017," concluded Michael Redmond.

PARALLAX HEALTH MANAGEMENT, INC. (FORMERLY QOLPOM, INC.)

Parallax Health Management, Inc. is a systems integration company focused on delivering state-of-the-art novel and branded tele-monitoring programs, medical devices and applications. The mission of Parallax Health Management is to deliver customized services that meet the unique needs of individual clients and their families. Parallax Health Management, Inc. offers the highest quality products and customizable monitoring solutions delivering quality of life for its users and peace of mind for those who care for and about them. Parallax Health Management, Inc. is currently developing proprietary software solutions for a next generation technology and support infrastructure for the home healthcare revolution. Parallax Health Management, Inc. is headquartered in Tucson, Arizona and its monitoring center in Tempe, Arizona. Please visit HYPERLINK "http://www.parallaxhealth.net/" nwww.parallaxhealth.net or HYPERLINK "http://www.parallaxhealthmanagement.com/" nwww.parallaxhealthmanagement.com.

ABOUT PARALLAX HEALTH SCIENCES, INC.

Parallax Health Sciences, Inc., headquartered in Santa Monica, CA, is a fully reporting Nevada corporation with its shares publicly traded on the OTC Markets under the stock symbol "HYPERLINK "http://www.nasdaq.com/symbol/prlx" nPRLX". Parallax is focused on personalized pharmaceutical solutions with Roxsan Pharmacy, Inc. and Roxsan Fertility Group, its wholly owned subsidiary Retail & Compound Pharmacy and Infertility business's licensed to operate in over 40 States and headquartered in Beverly Hills, California, and through Parallax Diagnostics, Inc., its point of care diagnostic subsidiary, which has an exclusive license, in perpetuity, to a line of point of care diagnostic tests on a single proprietary platform. Parallax Diagnostics plans to develop a novel, handheld diagnostic testing system based on Patents it has received in the United States, China, Hong Kong and Macao. This next generation POC platform offers the potential to transform the diagnostic landscape by transitioning critical tests from the centralized lab directly to the hands of the physician, caregivers or home use.